![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 20482 |
FusionGeneSummary for LYZ_SMG1 |
![]() |
Fusion gene information | Fusion gene name: LYZ_SMG1 | Fusion gene ID: 20482 | Hgene | Tgene | Gene symbol | LYZ | SMG1 | Gene ID | 4069 | 23049 |
Gene name | lysozyme | SMG1, nonsense mediated mRNA decay associated PI3K related kinase | |
Synonyms | LYZF1|LZM | 61E3.4|ATX|LIP | |
Cytomap | 12q15 | 16p12.3 | |
Type of gene | protein-coding | protein-coding | |
Description | lysozyme C1,4-beta-N-acetylmuramidase Cc-type lysozymelysozyme F1 | serine/threonine-protein kinase SMG1PI-3-kinase-related kinase SMG-1SMG1 phosphatidylinositol 3-kinase-related kinaselambda-interacting proteinlambda/iota protein kinase C-interacting proteinsmg-1 homolog, phosphatidylinositol 3-kinase-related kinase | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | P61626 | Q96Q15 | |
Ensembl transtripts involved in fusion gene | ENST00000261267, ENST00000549690, ENST00000548839, | ENST00000389467, ENST00000446231, ENST00000565224, ENST00000567737, | |
Fusion gene scores | * DoF score | 19 X 13 X 6=1482 | 7 X 8 X 4=224 |
# samples | 23 | 8 | |
** MAII score | log2(23/1482*10)=-2.68783968136146 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(8/224*10)=-1.48542682717024 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: LYZ [Title/Abstract] AND SMG1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | LYZ | GO:0031640 | killing of cells of other organism | 9727055 |
Hgene | LYZ | GO:0042742 | defense response to bacterium | 21093056 |
Hgene | LYZ | GO:0050830 | defense response to Gram-positive bacterium | 21093056 |
Tgene | SMG1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 11544179 |
Tgene | SMG1 | GO:0018105 | peptidyl-serine phosphorylation | 11544179|15175154 |
Tgene | SMG1 | GO:0046777 | protein autophosphorylation | 11331269|11544179 |
Tgene | SMG1 | GO:0046854 | phosphatidylinositol phosphorylation | 11331269 |
Tgene | SMG1 | GO:2001020 | regulation of response to DNA damage stimulus | 15175154 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | LAML | TCGA-AB-2875-03A | LYZ | chr12 | 69747265 | + | SMG1 | chr16 | 18819127 | - |
TCGA | LD | LAML | TCGA-AB-2911-03A | LYZ | chr12 | 69747259 | + | SMG1 | chr16 | 18819133 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
3UTR-3UTR | ENST00000261267 | ENST00000389467 | LYZ | chr12 | 69747265 | + | SMG1 | chr16 | 18819127 | - |
3UTR-3UTR | ENST00000261267 | ENST00000446231 | LYZ | chr12 | 69747265 | + | SMG1 | chr16 | 18819127 | - |
3UTR-intron | ENST00000261267 | ENST00000565224 | LYZ | chr12 | 69747265 | + | SMG1 | chr16 | 18819127 | - |
3UTR-intron | ENST00000261267 | ENST00000567737 | LYZ | chr12 | 69747265 | + | SMG1 | chr16 | 18819127 | - |
3UTR-3UTR | ENST00000549690 | ENST00000389467 | LYZ | chr12 | 69747265 | + | SMG1 | chr16 | 18819127 | - |
3UTR-3UTR | ENST00000549690 | ENST00000446231 | LYZ | chr12 | 69747265 | + | SMG1 | chr16 | 18819127 | - |
3UTR-intron | ENST00000549690 | ENST00000565224 | LYZ | chr12 | 69747265 | + | SMG1 | chr16 | 18819127 | - |
3UTR-intron | ENST00000549690 | ENST00000567737 | LYZ | chr12 | 69747265 | + | SMG1 | chr16 | 18819127 | - |
intron-3UTR | ENST00000548839 | ENST00000389467 | LYZ | chr12 | 69747265 | + | SMG1 | chr16 | 18819127 | - |
intron-3UTR | ENST00000548839 | ENST00000446231 | LYZ | chr12 | 69747265 | + | SMG1 | chr16 | 18819127 | - |
intron-intron | ENST00000548839 | ENST00000565224 | LYZ | chr12 | 69747265 | + | SMG1 | chr16 | 18819127 | - |
intron-intron | ENST00000548839 | ENST00000567737 | LYZ | chr12 | 69747265 | + | SMG1 | chr16 | 18819127 | - |
3UTR-3UTR | ENST00000261267 | ENST00000389467 | LYZ | chr12 | 69747259 | + | SMG1 | chr16 | 18819133 | - |
3UTR-3UTR | ENST00000261267 | ENST00000446231 | LYZ | chr12 | 69747259 | + | SMG1 | chr16 | 18819133 | - |
3UTR-intron | ENST00000261267 | ENST00000565224 | LYZ | chr12 | 69747259 | + | SMG1 | chr16 | 18819133 | - |
3UTR-intron | ENST00000261267 | ENST00000567737 | LYZ | chr12 | 69747259 | + | SMG1 | chr16 | 18819133 | - |
3UTR-3UTR | ENST00000549690 | ENST00000389467 | LYZ | chr12 | 69747259 | + | SMG1 | chr16 | 18819133 | - |
3UTR-3UTR | ENST00000549690 | ENST00000446231 | LYZ | chr12 | 69747259 | + | SMG1 | chr16 | 18819133 | - |
3UTR-intron | ENST00000549690 | ENST00000565224 | LYZ | chr12 | 69747259 | + | SMG1 | chr16 | 18819133 | - |
3UTR-intron | ENST00000549690 | ENST00000567737 | LYZ | chr12 | 69747259 | + | SMG1 | chr16 | 18819133 | - |
intron-3UTR | ENST00000548839 | ENST00000389467 | LYZ | chr12 | 69747259 | + | SMG1 | chr16 | 18819133 | - |
intron-3UTR | ENST00000548839 | ENST00000446231 | LYZ | chr12 | 69747259 | + | SMG1 | chr16 | 18819133 | - |
intron-intron | ENST00000548839 | ENST00000565224 | LYZ | chr12 | 69747259 | + | SMG1 | chr16 | 18819133 | - |
intron-intron | ENST00000548839 | ENST00000567737 | LYZ | chr12 | 69747259 | + | SMG1 | chr16 | 18819133 | - |
Top |
FusionProtFeatures for LYZ_SMG1 |
![]() |
Hgene | Tgene |
LYZ | SMG1 |
Lysozymes have primarily a bacteriolytic function; thosein tissues and body fluids are associated with the monocyte-macrophage system and enhance the activity of immunoagents. | Serine/threonine protein kinase involved in both mRNAsurveillance and genotoxic stress response pathways. Recognizesthe substrate consensus sequence [ST]-Q. Plays a central role innonsense-mediated decay (NMD) of mRNAs containing premature stopcodons by phosphorylating UPF1/RENT1. Recruited by release factorsto stalled ribosomes together with SMG8 and SMG9 (forming theSMG1C protein kinase complex), and UPF1 to form the transient SURF(SMG1-UPF1-eRF1-eRF3) complex. In EJC-dependent NMD, the SURFcomplex associates with the exon junction complex (EJC) throughUPF2 and allows the formation of an UPF1-UPF2-UPF3 surveillancecomplex which is believed to activate NMD. Also acts as agenotoxic stress-activated protein kinase that displays somefunctional overlap with ATM. Can phosphorylate p53/TP53 and isrequired for optimal p53/TP53 activation after cellular exposureto genotoxic stress. Its depletion leads to spontaneous DNA damageand increased sensitivity to ionizing radiation (IR). May activatePRKCI but not PRKCZ. {ECO:0000269|PubMed:11331269,ECO:0000269|PubMed:11544179, ECO:0000269|PubMed:15175154,ECO:0000269|PubMed:16452507}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for LYZ_SMG1 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for LYZ_SMG1 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
LYZ | KHK, LRRK1, NME2, LTF, PARP11, USP1, USP25, CUL4B, CDK2, COPS6, CLU, GRK5, CRK, SMAD6, STAU1, AURKA, CEP57, NEDD1, TP53, FUS, RPS6KB2, NTRK1, MCM2, CRYAB, DDX31, FRMD1, HBM, SNX27, WWOX, CYLD, CDK1, TRIM25 | SMG1 | PRKCI, SMG1, UPF1, UPF2, UPF3A, TTI1, TELO2, ELAVL1, SMG8, SMG9, RBM8A, UPF3B, NCBP2, PABPC1, SMG7, EIF4A3, MAGOH, GSPT2, GSPT1, EEF2, HSP90AA1, HSPA4, RUVBL1, RUVBL2, POLR2E, TUBA1A, TUBG1, HAUS2, HTR6, HSP90B1, EGFR, EPHA1 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for LYZ_SMG1 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for LYZ_SMG1 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | LYZ | C0268389 | Amyloidosis, familial visceral | 1 | CTD_human;UNIPROT |